# Syndax Pharmaceuticals Inc: Form 8-K, filed Dec 20, 2024

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: 8-K
- Filed: 2024-12-20
- Accepted by EDGAR: Dec 20, 2024, 17:00 ET
- Period: 2024-12-20
- Accession: 0000950170-24-139121
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000095017024139121/sndx-20241220.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000095017024139121/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000095017024139121/sndx-20241220.htm

Filed Dec 20, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-139121. Last ingested by Listed: Nov 2, 2026, 16:31 ET. No prices; not investment advice.